Physician Assistant Program year 2022 Reported 2021–2022 Source: CMS Open Payments, 2026 publication

Ella Krouse

Physician Assistant Charlotte, NC Physician Assistant

NPI 1669963237 CMS profile 10474733

501 Billingsley Rd, Ste B, Charlotte, NC 28211

Open in the dashboard

General payments

$5,454

311 records reported · program years 2021–2022

Research payments

$0

Paid to them · None reported · program years 2021–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Ella Krouse of Charlotte, NC is reported in the CMS Open Payments database as having received $5,454 across 311 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $1,800 100
2021 General $3,654 211

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ella Krouse
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Ella Krouse were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Ella Krouse Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $3,654 $132 $37–$438 $132
2022 $1,800 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2022
  1. AbbVie, Inc. $655 49 payments
  2. Teva Pharmaceuticals USA, Inc. $506 25 payments
  3. Otsuka America Pharmaceutical, Inc. $454 26 payments
  4. ITI, Inc. $449 24 payments
  5. Alkermes, Inc. $447 21 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $394 28 payments
  7. Janssen Pharmaceuticals, Inc $337 12 payments
  8. Neurocrine Biosciences, Inc. $329 20 payments
  9. Vanda Pharmaceuticals Inc. $257 18 payments
  10. Validus Pharmaceuticals LLC $237 1 payment
  11. Other $1,390 87 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2022
  1. Food and Beverage $5,313 308 payments
  2. Education $141 3 payments
Products named General payments · program years 2021–2022
  1. VRAYLAR $565 41 payments
  2. CAPLYTA $449 24 payments
  3. AUSTEDO $414 24 payments
  4. INVEGA SUSTENNA $316 11 payments
  5. REXULTI $280 13 payments
  6. LYBALVI Cns $270 11 payments
  7. LYBALVI Cns $270 11 payments
  8. HETLIOZ $257 18 payments
  9. FANAPT $257 18 payments
  10. INGREZZA $237 16 payments
  11. Other $4,326 238 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 38 drugs

Part D claims

1,839

Median for Physician Assistant: 241

Drug cost

$26,940

Median for Physician Assistant: $4,110

Branded share of claims

15.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Aripiprazole Generic 63 $3,245
Lurasidone Hcl Generic 15 $2,305
Quetiapine Fumarate Generic 143 $2,022
Trazodone Hcl Generic 129 $1,471
Olanzapine Generic 57 $1,406
Duloxetine Hcl Generic 86 $1,277
Divalproex Sodium Er Divalproex Sodium Brand 21 $1,023
Clonazepam Generic 158 $1,008
Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine Brand 23 $1,004
Venlafaxine Hcl Er Venlafaxine Hcl Brand 92 $995

The 10 drugs with the highest cost, of 38 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$2,372

Medicare's payments for the services billed

Medicare patients

18

Average age 54

Services billed

30

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 67%
Cancer 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

311 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record